{"organizations": [], "uuid": "08cc9d7c8b40cb2a5b5d5b1f3401d0989412c423", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/03/29/105098713-David_Krane.1910x1000.jpg", "site_section": "http://www.cnbc.com/id/19746125/device/rss/rss.xml", "section_title": "Top News and Analysis (pro)", "url": "https://www.cnbc.com/2018/03/30/alphabet-gv-life-sciences-and-health-investments-going-public.html", "country": "US", "domain_rank": 767, "title": "Alphabet's bets on health tech are paying off as portfolio companies go public", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-03-30T20:44:00.000+03:00", "replies_count": 0, "uuid": "08cc9d7c8b40cb2a5b5d5b1f3401d0989412c423"}, "author": "", "url": "https://www.cnbc.com/2018/03/30/alphabet-gv-life-sciences-and-health-investments-going-public.html", "ord_in_thread": 0, "title": "Alphabet's bets on health tech are paying off as portfolio companies go public", "locations": [], "entities": {"persons": [], "locations": [{"name": "bay area", "sentiment": "none"}, {"name": "silicon valley", "sentiment": "none"}], "organizations": [{"name": "tech guide alphabet", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "google", "sentiment": "none"}, {"name": "google ventures", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "As the first quarter comes to a close, three Bay Area life sciences companies have already gone public in 2018.\nGoogle parent company Alphabet has had a stake in two of them.\nThe company's venture arm, GV (formerly known as Google Ventures), has backed nearly 60 healthcare-related companies since it raised its first fund in 2009, making it one of the most active Silicon Valley players in the space.\nThose bets are starting to pay off: Five of GV's healthcare bets have gone public in the last year. \nGV owned a large enough stake in four of them — 10% or more — to be required to report as an insider with the SEC. \nThe market value for the firm's combined ownership of those four companies is roughly $153 million, according to data from FactSet:\nHere are the five companies, what they do, and when GV invested:\nSpero Therapeutics , a biopharmaceutical company creating treatments for bacterial infections, started trading on the Nasdaq last fall and has a current market cap of $204.8 million.\nGV led its Series C in March 2017 and its stake is now worth $15.79 million, according to FactSet. \nArsanis , which is working on antibody immunotherapies for infectious diseases, went public in November of last year and has a market cap of $327.2 million. GV invested in its Series D in April 2017 and its stake is worth $10.62 million, according to FactSet.\nArcus Bioscience , which develops cancer immunotherapies, went public in March and has a market cap of $657 million.\nGV first invested in Arcus' Series B in 2016 and again in its Series C in 2017, and its stake is worth $80.9 million, according to FactSet.\nARMO Biosciences fights cancer through immunotherapy. It went public in January 2018 has a market cap of $1.1 billion. GV invested in its Series C as well as its Series C-1 in 2016 and 2017 respectively, and its stake is currently worth $45.14 million.\nDenali Therapeutics creates therapies for neurodegenerative diseases like Alzheimer's and Parkinson's and went public in December 2017 and currently has a market cap of $1.86 billion. \nThere's a good chance 2018 will bring more excitement: Nasdaq's head of healthcare listings recently predicted that biotech M&A will be hot this year and that we could see 30+ total biotech IPOs. \nGV portfolio company 23andMe is expected to file before the end of the year.", "external_links": [], "published": "2018-03-30T20:44:00.000+03:00", "crawled": "2018-03-30T20:56:42.001+03:00", "highlightTitle": ""}